title: ["HAART-attack" in young female HIV-patient].
abstract: Since the implementation of highly active antiretroviral therapy (HAART) there is a dramatic decline in morbidity and mortality due to reduction of opportunistic infections in HIV-infected patients resulting in improved prognosis. Unfortunately, patients receiving HAART are at risk for metabolic complications, which may induce the development of coronary artery and cerebrovascular disease, particularly in young patients and in the presence of additional cardiovascular risk factors. A 30-years old female HIV-infected patient who developed an acute myocardial infarction is described.
authors.affiliation: Kardiologische Klinik, Universitätsspital Basel.
authors.forename: U
authors.initials: U
authors.lastname: Pittl
authors.forename: D I
authors.initials: DI
authors.lastname: Keller
authors.forename: C A
authors.initials: CA
authors.lastname: Kaiser
authors.forename: M
authors.initials: M
authors.lastname: Battegay
authors.forename: M E
authors.initials: ME
authors.lastname: Pfisterer
authors.forename: A
authors.initials: A
authors.lastname: Linka
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D020099:Coated Materials, Biocompatible; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D003937:Diagnosis, Differential; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents
chemical_list: D020099:Coated Materials, Biocompatible; D020123:Sirolimus